🇺🇸 FDA
Patent

US 8388969

Interleukin-1 alpha antibodies and methods of use

granted A61KA61K2039/55527A61K39/3955

Quick answer

US patent 8388969 (Interleukin-1 alpha antibodies and methods of use) held by XBIOTECH INC. expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XBIOTECH INC.
Grant date
Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K2039/55527, A61K39/3955, A61P, A61P29/00